clesrovimab
Generic: clesrovimab·Brand: Enflonsia
clesrovimab: 1 clinical trial tracked.
clesrovimab evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about clesrovimab, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
Clinical Trial Registry Records (1)
A Phase 2b/3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MK-1654 in Healthy Pre-Term and Full-Term Infants
Primary endpoint: RSV Season 1: Number of Participants With Respiratory Syncytial Virus (RSV)-Associated Medically Attended Lower Respiratory Infection (MALRI)
InterventionalRandomizeddouble3,632 enrolledStarted 2021-04Completion 2024-0750 sites · United StatesMerck Sharp & Dohme LLC